Menu Back toSession 4: General Session: Emergency Use Authorizations (EUA) Panel DIscussion

Medical Affairs and Scientific Communications Forum

DIA Your Way! Join us live in-person or live from the comfort of your home/office. This event offers two learning avenues depending on your preference!

Session 4: General Session: Emergency Use Authorizations (EUA) Panel DIscussion

Session Chair(s)

Lakshmi  Ramkumar

Lakshmi Ramkumar

  • Senior Director, Head of Medical Writing
  • Moderna, United States
Karen Joyce Hager, MS

Karen Joyce Hager, MS

  • Director, Clinical Trial Management, Global Clinical Operations
  • Vertex Pharmaceuticals, United States
The panel will take questions about the EUA submission process and share lessons learned and recommendations for agile submission practices with the audience. There will be emphasis on impact on Medical Writing function.
Learning Objective : At the conclusion of this session, participants should be able to:
  • Discuss tips for optimizing the submission timeline and determine when to escalate
  • Identify one or more tips for clear effective communication to facilitate the progress the submission timeline
  • Define roles and responsibilities of the submission team (i.e. RACI use)